Pereira M S, Mulloy B, Mourão P A
Laboratório de Tecido Conjuntivo, Hospital Universitário, Departamento de Bioquímica Médica, Centro de Ciências da Saúde, Universidade Federal do Rio de Janeiro, Caixa Postal 68041, Rio de Janeiro, RJ 21941-590, Brazil.
J Biol Chem. 1999 Mar 19;274(12):7656-67. doi: 10.1074/jbc.274.12.7656.
Sulfated fucans are among the most widely studied of all the sulfated polysaccharides of non-mammalian origin that exhibit biological activities in mammalian systems. Examples of these polysaccharides extracted from echinoderms have simple structures, composed of oligosaccharide repeating units within which the residues differ by specific patterns of sulfation among different species. In contrast the algal fucans may have some regular repeating structure but are clearly more heterogeneous when compared with the echinoderm fucans. The structures of the sulfated fucans from brown algae also vary from species to species. We compared the anticoagulant activity of the regular and repetitive fucans from echinoderms with that of the more heterogeneous fucans from three species of brown algae. Our results indicate that different structural features determine not only the anticoagulant potency of the sulfated fucans but also the mechanism by which they exert this activity. Thus, the branched fucans from brown algae are direct inhibitors of thrombin, whereas the linear fucans from echinoderms require the presence of antithrombin or heparin cofactor II for inhibition of thrombin, as reported for mammalian glycosaminoglycans. The linear sulfated fucans from echinoderms have an anticoagulant action resembling that of mammalian dermatan sulfate and a modest action through antithrombin. A single difference of one sulfate ester per tetrasaccharide repeating unit modifies the anticoagulant activity of the polysaccharide markedly. Possibly the spatial arrangements of sulfate esters in the repeating tetrasaccharide unit of the echinoderm fucan mimics the site in dermatan sulfate with high affinity for heparin cofactor II.
硫酸化岩藻聚糖是所有非哺乳动物来源的具有生物活性的硫酸化多糖中研究最为广泛的一类。从棘皮动物中提取的这些多糖的例子结构简单,由寡糖重复单元组成,不同物种的重复单元内残基的硫酸化模式不同。相比之下,藻类岩藻聚糖可能具有一些规则的重复结构,但与棘皮动物岩藻聚糖相比明显更加不均一。褐藻硫酸化岩藻聚糖的结构也因物种而异。我们比较了棘皮动物规则且重复的岩藻聚糖与三种褐藻中更为不均一的岩藻聚糖的抗凝血活性。我们的结果表明,不同的结构特征不仅决定了硫酸化岩藻聚糖的抗凝血效力,还决定了它们发挥这种活性的机制。因此,褐藻中的分支岩藻聚糖是凝血酶的直接抑制剂,而棘皮动物中的线性岩藻聚糖则需要抗凝血酶或肝素辅因子II的存在才能抑制凝血酶,这与哺乳动物糖胺聚糖的情况相同。棘皮动物中的线性硫酸化岩藻聚糖具有类似于哺乳动物硫酸皮肤素的抗凝血作用,并且通过抗凝血酶有适度作用。每四个糖重复单元中一个硫酸酯的单一差异会显著改变多糖的抗凝血活性。可能棘皮动物岩藻聚糖重复四糖单元中硫酸酯的空间排列模拟了硫酸皮肤素中对肝素辅因子II具有高亲和力的位点。